Automatic dispensing system on influence of work efficiency of outpatient pharmacy and the safety of prevention and control of COVID-19

doi:10.19803/j.1672-8629.2022.05.20

Abstract

Abstract: Objective To analyse the impact of the automatic dispensing system on the work efficiency of outpatient pharmacies and the safety of COVID-19 prevention. Methods The hospital information system (HIS) data of the outpatient pharmacy with or without the automatic dispensing system and the related data of the automatic dispensing system were adjusted in two adjacent hospitals with similar department settings, layouts, and patient types. And pharmacists and patients were surveyed. The data and questionnaire results were compared and analyzed. Results and Conclusion The pharmacists in the hospital with the automatic dispensing system are more accurate and quicker. The dispensing process is more reasonable and efficient. The internal staff of the pharmacy is less. The regional division is more reasonable. The prevention and control level is clearer and the working environment is safer. The waiting time is more reasonable and the time for drug taking is shorter. Reduce aggregation and reduce the risk of cross-contamination.

Key words: automatic dispensing system, outpatient pharmacy, work efficiency, COVID-19, epidemic prevention and control

CLC Number:

R952

ZHAO Xuan, GUO Jing, MEI Long, ZHANG Wei. Automatic dispensing system on influence of work efficiency of outpatient pharmacy and the safety of prevention and control of COVID-19[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 564-567.

References

[1] ZHOU JW.Influence of architectural planning and design concept of infectious disease hospital on disease transmission[J]. Anti-Infection Pharmacy(抗感染药学), 2018, 15(9): 1544-1546.
[2] SHEN Y Y.Discussion on inner er ror analysis of outpatient prescriptions dispensing and preventive measures[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2013, 10(11): 693-695.
[3] LI L, SI YM, HE CB.Application of automatic dispensing machine in outpatient pharmacy[J]. Journal of Traditional Chinese Medicine Management(中医药管理杂志), 2012, 20(12): 1233-1234.
[4] LI LZ, YANG JC, LIANG HL, et al.Analysis of the outpatient pharmacy work before and after the application of the automatic dispensing machine[J]. Pharmacy Today(今日药学), 2018, 28(6): 418-420.
[5] ZHENG D.Cause analysis and preventive countermeasures of dispensing errors in outpatient pharmacy[J]. Journal of Clinical Medical(临床医药文献电子杂志), 2017, 4(75): 14847-14848.
[6] Expert Group of China Intelligent Pharmaceutical Alliance. Expert consensus on accelerating the development of intelligent pharmaceutical care during the epidemic of Corona Virus Disease 2019(2nd edition)[J]. Clinical Medication Journal(临床药物治疗杂志), 2020, 18(6): 11-25.
[7] ZHU HJ.Application of automated dispensing system in outpatient pharmacy of our hospital[J]. China Pharmaceuticals(中国药业), 2014, 23(14): 76-77.
[8] CHEN XJ, SHI LY, ZHOU XY.Evaluation and analysis of the advantages and disadvantages about introducing the automatic drug dispensing machine in outpatient pharmacy of hospital[J]. China Medical Herald(中国医药导报), 2016, 13(19): 143-146.
[9] ZHANG SB.Practice and exploration of automatic dispensing machine in outpat ient pha r macy of ou r hospit a l[J ]. St ra it Pharmaceutical Journal(海峡药学), 2021, 33(8): 189-190.
[10] WEI J, ZHU Y.Application effect of automatic dispensing system in outpatient pharmacy[J]. Guangxi Medical Journal(广西医学), 2017, 39(10): 1615-1617.
[11] ZHANG S, TONG F, WANG XE, et al.The management and practice of automated dispensing cabinet in clinical use[J]. Journal of North Pharmacy(北方药学), 2019, 16(7): 155-157.
[12] SA NG WT, Y U F R , L I B, et a l. Application of automatic dispensing machine in outpatient pharmacy of a hospital[J]. China Pharmaceuticals(中国药业), 2019, 28(22): 84-87.
[13] CHEN J, ZHANG X.Discussion on the management and connection mode of intelligent medicine cabinet[J]. Chinese Journal of Health Informatics and Management(中国卫生信息管理杂志), 2019, 16(3): 322-326.
[14] WAN M, SHEN DX, ZHU YB, et al.Application effect of intelligent equipment in outpatient pharmacy in post epidemic period[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药杂志), 2021, 14(31): 148-152.

[1]	ZHANG Jingsheng, JI Zuen, PANG Bo, XU Yingli, CAO Shan, ZHANG Yu, SUN Qiyue, SUN Jing, LI Shuran, ZHANG Wei, ZHAO Ronghua, CUI Xiaolan. Discussion on traditional Chinese medicine theory and modern pharmacology of Xuanfei Baidu decoction for treating novel coronavirus infection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 55-58.
[2]	LI Shuran, GUO Shanshan, JI Zuen, ZHANG Wei, CUI Xiaolan. Research status of cognitive dysfunction after SARS-CoV-2 infection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 59-64.
[3]	LI Jing, XU Ye, LIU Ranjia, PAN Chen, CUI Xiangli. Adverse reactions in patients with COVID-19 after using tocilizumab [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1049-1053.
[4]	YANG Qiuyue, SU Jun, ZHANG Xue, XIE Jiangan. Adverse events associated with the three US licensed COVID-19 vaccines based on VAERS database [J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1141-1147.
[5]	GE Ziruo, TIAN Di, WANG Aibin, ZHANG Tingyu, REN Xingxiang, QIAN Fang, LI Xingwang, CHEN Zhihai. Therapeutic effect of interferon atomization against COVID-19 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 733-739.
[6]	WANG Tiezhu. Signal detection and analysis of adverse reaction of hydroxychloroquine sulfate induced visual impairment [J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 657-660.
[7]	YANG Fan, MA Haiping, YOU Mengru, LIAO Sha, LIU Lan, ZHU Jun. Applications of antiviral drugs in 456 patients with COVID-19 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 413-416.
[8]	ZHOU Boya, YUAN Sisi, FENG Xin. Research progress in effects of lopinavir / ritonavir used by lactating females on sucklings [J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 296-301.
[9]	GUO Jun, REN Dan, YE Long, ZHAO Rongxiang, WANG Yu, YU Jing. Spontaneous muscular hemorrhage induced by warfarin tablets in a child [J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 339-341.
[10]	XIONG Jing, LIU Yi, LIU Zhaoxia, LI Jie, ZHANG Caiyu, WU Xiangxiang, HE Lan. Development of the first national reference substance of ritonavir as a candidate drug against COVID-19 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 137-141.
[11]	LI Tianyu, JIA Yijiang, WANG Yuji, WANG Jinhui, LI Ye. Research progress of treatment drugs for SARS-CoV-2 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1266-1271.
[12]	ZHAO Zhe, ZHANG Qing, GE Ziruo, ZHANG Wei, CHEN Zhihai. Giant progress in small molecule antiviral drugs for SARS-CoV-2 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 1-6.
[13]	XIONG Jing, YAN Jing, LIU Yi, LIU Yang, HE Lan. Development of the first national reference substance of favipiravir as a candidate drug against COVID-19 [J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 52-56.
[14]	ZHAO Xuan, GUO Jing, REN Shuang, ZHEN Jiancun. Management and working modes of outpatient pharmacies amid routine COVID-19 epidemic prevention [J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 100-102.
[15]	WU Fei, LI Min, FANG Yuting, CHEN Yongwu, SHEN Aizong. Active Monitoring of Adverse Drug Reactions Caused by Lopinavir/ritonavir in Treating Coronavirus Disease 2019 [J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 105-109.